FBT ETF holdings
Weights reproduce the dated portfolio and may not sum to exactly 100% because of cash, derivatives, rounding, liabilities, or other positions. Provenance stays internal.
| Snapshot field | Reported value |
|---|
| Fund | First Trust NYSE Arca Biotechnology Index Fund |
|---|
| Report date | 2026-03-31 |
|---|
| Reported holdings | 32 |
|---|
| SEC series ID | S000012478 |
|---|
Positions 1–32 of 32
| Ticker | Issuer | Weight | Value (USD) | Balance |
|---|
| MRNA | Moderna Inc | 5.261478% | 119,445,481.2 | 2,351,289 NS |
|---|
| UTHR | United Therapeutics Corporation | 4.358145% | 98,938,120.02 | 166,849 NS |
|---|
| ALKS | Alkermes PLC | 4.235159% | 96,146,103.04 | 2,719,064 NS |
|---|
| GILD | Gilead Sciences Inc. | 4.088616% | 92,819,305.04 | 665,992 NS |
|---|
| AXSM | Axsome Therapeutics Inc. | 3.885484% | 88,207,819.56 | 521,878 NS |
|---|
| AMGN | Amgen Inc. | 3.832568% | 87,006,523.55 | 247,283 NS |
|---|
| CORT | Corcept Therapeutics Inc. | 3.818702% | 86,691,734.06 | 2,150,626 NS |
|---|
| KRYS | Krystal Biotech Inc | 3.510402% | 79,692,753.28 | 308,504 NS |
|---|
| BIIB | Biogen Inc | 3.471295% | 78,804,950.49 | 429,853 NS |
|---|
| EXEL | Exelixis, Inc. | 3.459764% | 78,543,170.3 | 1,831,270 NS |
|---|
| NBIX | Neurocrine Biosciences Inc | 3.446577% | 78,243,811.24 | 593,926 NS |
|---|
| REGN | Regeneron Pharmaceuticals, Inc. | 3.445926% | 78,229,027.36 | 101,249 NS |
|---|
| VRTX | Vertex Pharmaceuticals Incorporated | 3.419268% | 77,623,834.36 | 173,834 NS |
|---|
| BMRN | Biomarin Pharmaceutical Inc. | 3.404148% | 77,280,579.6 | 1,368,040 NS |
|---|
| ARGX | Argenx SE | 3.291481% | 74,722,831.25 | 102,325 NS |
|---|
| SRPT | Sarepta Therapeutics Inc | 3.24393% | 73,643,325.44 | 3,384,344 NS |
|---|
| HALO | Halozyme Therapeutics Inc | 3.168153% | 71,923,043.09 | 1,112,843 NS |
|---|
| BNTX | BioNTech SE | 3.162264% | 71,789,353.68 | 807,711 NS |
|---|
| INCY | Incyte Corporation. | 3.128633% | 71,025,869.72 | 754,631 NS |
|---|
| ONC | BEONE MEDICINES LTD | 3.122138% | 70,878,423.84 | 238,672 NS |
|---|
| ILMN | Illumina Inc | 3.104216% | 70,471,563.06 | 571,731 NS |
|---|
| NTRA | NATERA INC | 3.032178% | 68,836,158.02 | 344,198 NS |
|---|
| ACAD | Acadia Pharmaceuticals Inc | 2.952877% | 67,035,878.7 | 3,011,495 NS |
|---|
| ALNY | Alnylam Pharmaceuticals Inc. | 2.951232% | 66,998,528.04 | 202,492 NS |
|---|
| TECH | Bio-Techne Corp | 2.825891% | 64,153,069.5 | 1,227,575 NS |
|---|
| GMAB | Genmab As | 2.782074% | 63,158,329.77 | 2,354,019 NS |
|---|
| VCYT | Veracyte Inc | 2.72179% | 61,789,763.61 | 1,918,341 NS |
|---|
| RGEN | Repligen Corporation | 2.508958% | 56,958,076.06 | 483,433 NS |
|---|
| BRKR | Bruker Corporation | 2.356233% | 53,490,938.76 | 1,480,923 NS |
|---|
| NEO | Neogenomics Inc | 2.002997% | 45,471,822.76 | 6,128,278 NS |
|---|
| MISXX | Dreyfus Government Cash Management Funds | 0.062285% | 1,413,994.11 | 1,413,994.11 NS |
|---|
| DAIWA CAPITAL MARKETS AMERICA INC. | DAIWA CAPITAL MARKETS AMERICA INC. | 0.008303% | 188,488 | 188,488 PA |
|---|